New Jersey’s life sciences sector is poised for continued growth in 2024, following a year in which the industry was a key source of demand for commercial real estate owners.
Life sciences companies remain a leading driver of commercial real estate in New Jersey, accounting for more than a third of all office leases during the first half of 2023 and fueling a pipeline of deals for lab and manufacturing space.
